ClearOne Inc. (CLRO) cancels 437,500-share warrant in merger
Rhea-AI Filing Summary
First Finance Ltd. reported disposition transactions in this Form 4 filing.
CLEARONE INC disclosed that 10% owner First Finance Ltd. entered into a Warrant Cancellation Agreement on August 4, 2026, surrendering a Common Stock Purchase Warrant for 437,500 shares of common stock with a $5.00 exercise price for no consideration, pursuant to an Agreement and Plan of Merger involving Cortigent and Vivani Medical, leaving First Finance with no derivative securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
First Finance Ltd., HROMYK ANDREW
Role
10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock Purchase Warrant F1 | 437,500 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock Purchase Warrant — 0 shares (Direct)
Footnotes (1)
- F1. On August 4, 2026, pursuant to the Agreement and Plan of Merger by and among ClearOne, Inc. (the "Issuer"), CLRO Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), Cortigent, Inc. ("Cortigent"), and Vivani Medical, Inc., pursuant to which Merger Sub will merge with and into Cortigent, with Cortigent surviving as a wholly-owned subsidiary of the Issuer, First Finance Ltd. entered into a Warrant Cancellation Agreement with the Issuer pursuant to which First Finance Ltd. surrendered and cancelled the Common Stock Purchase Warrant in its entirety for no consideration. As a result of the Warrant Cancellation Agreement, First Finance Ltd. no longer holds any derivative securities of the Issuer. The Common Stock Purchase Warrant was exercisable six months from the original closing date (March 6, 2026) and was set to expire two years from the closing date.
Key Figures
Warrant shares cancelled: 437,500 shares
Exercise price: $5.00 per share
Derivative holdings after cancellation: 0 derivative securities
+3 more
6 metrics
Warrant shares cancelled
437,500 shares
Common Stock Purchase Warrant cancelled on August 4, 2026
Exercise price
$5.00 per share
Conversion or exercise price of the cancelled Common Stock Purchase Warrant
Derivative holdings after cancellation
0 derivative securities
First Finance Ltd. post-transaction derivative position in ClearOne
Original closing date
March 6, 2026
Original closing date from which warrant exercisability and expiry were measured
Exercisability delay
6 months
Warrant was exercisable six months from the March 6, 2026 closing date
Warrant term
2 years
Warrant was set to expire two years from the March 6, 2026 closing date
Key Terms
Agreement and Plan of Merger, Warrant Cancellation Agreement, Common Stock Purchase Warrant, wholly-owned subsidiary, +1 more
5 terms
Agreement and Plan of Merger regulatory
"pursuant to the Agreement and Plan of Merger by and among ClearOne, Inc."
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Warrant Cancellation Agreement financial
"First Finance Ltd. entered into a Warrant Cancellation Agreement with the Issuer"
Common Stock Purchase Warrant financial
"surrendered and cancelled the Common Stock Purchase Warrant in its entirety"
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
wholly-owned subsidiary financial
"Merger Sub will merge with and into Cortigent, with Cortigent surviving as a wholly-owned subsidiary"
A wholly-owned subsidiary is a company whose entire ownership is held by another company, called the parent, so the parent controls all shares, board appointments and major decisions. For investors this matters because the subsidiary’s profits, losses, assets and liabilities are treated as part of the parent’s financial picture, affecting valuation and risk exposure — imagine a parent owning a single storefront outright and consolidating its receipts and bills into the parent’s books.
derivative securities financial
"As a result of the Warrant Cancellation Agreement, First Finance Ltd. no longer holds any derivative securities"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction was reported for ClearOne (CLRO) in this Form 4?
The filing reports that 10% owner First Finance Ltd. cancelled a Common Stock Purchase Warrant for 437,500 shares of ClearOne common stock for no consideration under a Warrant Cancellation Agreement linked to an Agreement and Plan of Merger involving Cortigent and Vivani Medical.
What were the key terms of the cancelled warrant in ClearOne (CLRO)?
The cancelled Common Stock Purchase Warrant covered 437,500 underlying shares of ClearOne common stock at an exercise price of $5.00 per share. It would have become exercisable six months after the March 6, 2026 closing date and was scheduled to expire two years from that closing.
Why was the ClearOne (CLRO) warrant cancelled by First Finance Ltd.?
First Finance Ltd. cancelled the warrant pursuant to an Agreement and Plan of Merger among ClearOne, CLRO Merger Sub, Cortigent, and Vivani Medical. Under a Warrant Cancellation Agreement with ClearOne, the warrant was surrendered and cancelled in its entirety for no consideration on August 4, 2026.
How many derivative securities does First Finance Ltd. hold in ClearOne (CLRO) after this Form 4?
Following the Warrant Cancellation Agreement, First Finance Ltd. no longer holds any derivative securities of ClearOne. The reported Common Stock Purchase Warrant for 437,500 shares was fully surrendered and cancelled, and the post-transaction derivative holdings reported in the filing are 0.
What is the timing and duration of the cancelled ClearOne (CLRO) warrant?
The warrant was originally issued with a closing date of March 6, 2026, set to become exercisable six months later and to expire two years from that closing. It was instead cancelled on August 4, 2026 under the Warrant Cancellation Agreement before becoming exercisable.